PCSK9 inhibitors × blood pressure

Observational studyCardiovascular diabetology2020

Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.

Jie Shi et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation, not cause

Went with higher blood pressure

2.2×1.2× to 4×

Bigger than 8 in 10 on the map

As reported

HR 2.16, 95% CI 1.16–4.04

One number in the abstract

the abstract, start to end

PCSK9 quartile group (hazard ratio 2.16; 95% confidence interval

← favours treatmentfavours comparator →
could be chance
Blood pressure
HR 2.161.16–4.04
PCSK9 inhibitorsBlood pressure
1 / 3

17 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33302966